Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2Zhihao Liu, Luoting Yu, Xingping Su et al.|Journal of Medicinal Chemistry|2021Cited by 116
Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of CancerGuoquan Wan, Luoting Yu, Zhanzhan Feng et al.|Journal of Medicinal Chemistry|2022Cited by 28
Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian CancerQiangsheng Zhang, Luoting Yu, Xinyi Chen et al.|Journal of Medicinal Chemistry|2023Cited by 24